Velosbio

Developer of therapeutic solutions for the treatment of cancer

placeSan Diego, California, United States calendar_todayFounded 2017 groups30 employees language velosbio.com

Registered entities

Innovation

5 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 577 times.

YearFilings
20181
20191
20203
20214
20225
20233
20242
20255
20261

Investor mix

20 investors on record; lead investors include Arix Bioscience, Sofinnova Investments, Matrix Capital Management, Citadel; 1 has since exited.

Investor typeCountShare
Venture capital1260%
Private equity15%
Bank & private debt210%
Other / undisclosed525%
Coming soon